Form 4 for RVMD Revolution Medicines, Inc.
Accepted 2023-10-25 00:00:00 ET · period of report 2023-10-25 · accession 0001610717-23-000315 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-10-25 | 2023-10-25 | RVMD | Horn Margaret A | COO | M - OptEx | $0.54 | +7,500 | 104.5K | +8% | +$4,050 |
| D | 2023-10-25 | 2023-10-25 | RVMD | Horn Margaret A | COO | M - OptEx | $0.00 | -7,500 | 5,941 | -56% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-10-25 | M | A | 7,500 | $0.54 | 104,460 | D | — | — | (F1) Includes 64,875 restricted stock units. |
| 2 | Derivative | Stock Option (Right to Buy) | 2023-10-25 | M | D | 7,500 | $0.00 | 5,941 | D | $0.54 · 2022-03-01 to 2028-02-11 | 7,500 Common Stock |